News for Healthier Living

Global Study Marks Major Treatment Advance for Tough-to-Treat High-Risk Blood Cancer

Results from a new clinical trial led by Wake Forest University School of Medicine and Atrium Health Levine Cancer shows a new therapy could provide significantly better outcomes for patients with high-risk essential thrombocythaemia (ET), a type of blood cancer.

February 9, 2026


February 10 2026

February 9 2026

February 8 2026

February 7 2026

February 6 2026

February 5 2026

February 4 2026

February 3 2026

February 2 2026

February 1 2026

January 31 2026

January 30 2026

January 29 2026

January 28 2026

January 27 2026